8-K/A
Current Report
Viridian Therapeutics, Inc.DE Filed Acc 0001193125-18-096752
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d361104d8ka.htm…